Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2013

View Archived Issues

New milestone under Ono Pharmaceutical and Receptos' GPCR collaboration

Novel nanoparticles shown to suppress choroidal neovascularization

Sirolimus demonstrates safety in patients with uveitis

ADMA Biologics begins pivotal phase III study of RI-002 in PIDD

Hangzhou Bensheng Pharmaceutical divulges novel agents for cancer

GlaxoSmithKline synthesizes bromodomain-containing protein inhibitor

reMYND patents new agents for tauopathies

Janssen and Bayer launch global cardiovascular research program for Xarelto

Incyte Corp. prepares new series of JAK1 inhibitors

Vitamin D deficiency associated with psoriasis severity

New mutations identified in Gorlin-Goltz syndrome

Norendoxifen as a new lead compound for aromatase inhibitor development

Researchers at Piramal Imaging design new diagnostics for thrombosis

Cellceutix plans future Kevetrin trials

Merck & Co. submits BLA for ragweed AIT

Non-inferiority reported in phase III trial of the seasonal flu vaccine ASP-7374

Theravance grants Clinigen exclusive commercialization rights to Vibativ in the E.U.

Retrophin reports data from preclinical studies of RE-024

Amgen synthesizes novel sodium channel blockers

Aeterna Zentaris to stop phase III trial of combination regimen using perifosine

Sosei initiates phase III study of mucoadhesive buccal tablet for oropharyngeal candidiasis

ZIOPHARM Oncology begins phase II study of Ad-RTS IL-12 combined with palifosfamide

Autologous CDC therapy proves to be safe and effective in patients post-MI

TONIX Pharmaceuticals and the FDA discuss NDA plan for TNX-102

NeuroVive acquires novel cyclophilin inhibitors from Biotica

Astellas and Ambit terminate collaboration for FLT3 kinase inhibitors

Telormedix commences enrollment in phase II trial in bladder cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...